Concepedia
Statistics
Publications
18
Citations
1.7K
H-Index
16
Active since
2003
Affiliations
BC Cancer Agency(Current)
University of British Columbia
Abbotsford Veterinary Clinic
Juravinski Cancer Centre
Tampere University
Muhammad Zulfiqar is an author at BC Cancer Agency specializing in medicine, pharmacotherapy, and urology.
Top concepts
MedicineUrologyOncologyPharmacotherapyHealthCancer TherapyPathologyPharmacologyClinical TrialsRadiation Oncology
Publications per year
2003–2024
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala, Gillian Vandekerkhove, Daniel Khalaf et al. · Cancer Discovery · 2018 · 507 citations · Full text
Pathology, Rapid Resistance, Invasive Biomarkers +17
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
Daniel Khalaf, Matti Annala, Sinja Taavitsainen et al. · The Lancet Oncology · 2019 · 338 citations
Urology, Oncology, Optimal Sequencing +8
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
Sharlene Gill, Yoo‐Joung Ko, C. Cripps et al. · Journal of Clinical Oncology · 2016 · 282 citations
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Nicolette M. Fonseca, Corinne Maurice‐Dror, Cameron Herberts et al. · Nature Communications · 2024 · 101 citations · Full text
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Matti Annala, Sinja Taavitsainen, Daniel Khalaf et al. · Clinical Cancer Research · 2021 · 91 citations · Full text
1–5 of 18